Antigenicity and immunogenicity of collagen
Source abstract
Abstract
Abstract Pertinent issues of collagen antigenicity and immunogenicity are concisely reviewed as they relate to the design and application of biomedical devices. A brief discussion of the fundamental concepts of collagen immunochemistry is presented, with a subsequent review of documented clinical responses to devices containing reconstituted soluble or solubilized collagen. The significance of atelocollagen, concerns regarding collagen‐induced autoimmunity, and other relevant topics are also addressed in the context of current understanding of the human immune response to collagen. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 71B: 343–354, 2004
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Collagen: Extraction and Characterization · Cell Adhesion Molecules Research · Osteoarthritis Treatment and Mechanisms
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Li ST · 1995 · 627
2. Gorham SD · 1991 · 5510.1007/978-1-349-11167-1_2 ↗
3. 10.1111/j.1442-9071.1996.tb01589.x10.1111/j.1442-9071.1996.tb01589.x ↗
4. 10.1001/archderm.120.7.837c10.1001/archderm.120.7.837c ↗
5. 10.1001/archotol.1984.0080036002400510.1001/archotol.1984.00800360024005 ↗
6. 10.1046/j.1524-4725.1999.8228a.x10.1046/j.1524-4725.1999.8228a.x ↗
7. 10.4049/jimmunol.136.3.87710.4049/jimmunol.136.3.877 ↗
8. Avitene granulomas of colonic serosa
9. 10.1097/00003086-200002000-0000310.1097/00003086-200002000-00003 ↗
10. 10.1016/0306-9877(95)90195-710.1016/0306-9877(95)90195-7 ↗
11. 10.1097/00001573-200003000-0000210.1097/00001573-200003000-00002 ↗
12. 10.1097/00001573-199903000-0000210.1097/00001573-199903000-00002 ↗
13. 10.1080/1532179720806816010.1080/15321797208068160 ↗
14. 10.1016/S0939-6411(98)00017-410.1016/S0939-6411(98)00017-4 ↗
15. 10.1016/B978-0-12-363707-9.50008-310.1016/B978-0-12-363707-9.50008-3 ↗
16. 10.1007/978-1-4757-4602-0_710.1007/978-1-4757-4602-0_7 ↗
17. 10.1002/jbm.82020011010.1002/jbm.820200110 ↗
18. 10.1016/S0741-5214(94)70071-010.1016/S0741-5214(94)70071-0 ↗
19. 10.1097/00007890-198302000-0001210.1097/00007890-198302000-00012 ↗
20. 10.1016/S0022-5223(20)31465-310.1016/S0022-5223(20)31465-3 ↗
21. 10.1016/0142-9612(96)82721-910.1016/0142-9612(96)82721-9 ↗
22. 10.1002/jbm.82014060710.1002/jbm.820140607 ↗
23. 10.1016/B978-0-12-635502-4.50008-410.1016/B978-0-12-635502-4.50008-4 ↗
24. 10.1002/jbm.82028011210.1002/jbm.820280112 ↗
25. 10.1001/archderm.125.8.108410.1001/archderm.125.8.1084 ↗
26. 10.1016/B978-0-12-363707-9.50007-110.1016/B978-0-12-363707-9.50007-1 ↗
27. 10.1016/0014-5793(71)80010-810.1016/0014-5793(71)80010-8 ↗
28. 10.1084/jem.126.2.33110.1084/jem.126.2.331 ↗
29. 10.1126/science.166.3912.152210.1126/science.166.3912.1522 ↗
30. 10.1111/j.1432-1033.1970.tb01051.x10.1111/j.1432-1033.1970.tb01051.x ↗
31. Conformation dependence of antigenic determinants on the collagen molecule
32. 10.1016/0019-2791(72)90258-310.1016/0019-2791(72)90258-3 ↗
33. Specificity of the antibody response in inbred mice to bovine type I and type II collagen
34. 10.1172/JCI11392910.1172/JCI113929 ↗
35. 10.1002/eji.183003071310.1002/eji.1830030713 ↗
36. The production of specific antibodies to native collagens with the chain compositions, (alpha1(I))3, (alpha1(II))3, and (alpha1(I))2alpha 210.4049/jimmunol.113.1.421 ↗
37. 10.1046/j.1525-1594.2003.07073.x10.1046/j.1525-1594.2003.07073.x ↗
38. 10.1016/S0142-9612(03)00222-910.1016/S0142-9612(03)00222-9 ↗
39. 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K ↗
40. Luck EE Daniels JR inventors;Collagen Corporation assignee.US4233360: Non‐antigenic collagen and articles of manufacture. USA.1980.
41. Requirement for T cells in the antibody response of mice to calf skin collagen
42. 10.1084/jem.139.1.14810.1084/jem.139.1.148 ↗
43. 10.1016/S0190-9622(84)80271-610.1016/S0190-9622(84)80271-6 ↗
44. 10.1016/S0190-9622(84)80272-810.1016/S0190-9622(84)80272-8 ↗
45. 10.1016/S0190-9622(89)70330-310.1016/S0190-9622(89)70330-3 ↗
46. 10.1046/j.1524-4725.1999.08186.x10.1046/j.1524-4725.1999.08186.x ↗
47. 10.1034/j.1398-9995.2000.00107.x10.1034/j.1398-9995.2000.00107.x ↗
48. 10.1111/1523-1747.ep1246902310.1111/1523-1747.ep12469023 ↗
49. Latex allergy: How safe are your gloves?
50. 10.1111/j.1524-4725.1989.tb03163.x10.1111/j.1524-4725.1989.tb03163.x ↗
51. 10.1097/00006534-197610000-0000110.1097/00006534-197610000-00001 ↗
52. 10.1016/0266-7681(89)90131-910.1016/0266-7681(89)90131-9 ↗
53. Catgut allergy (case report)
54. Correlation between allergy to suture material and postoperative wound infections
55. 10.1002/bies.95003030610.1002/bies.950030306 ↗
56. 10.1097/00006534-199509000-0001510.1097/00006534-199509000-00015 ↗
57. 10.1111/j.1524-4725.1989.tb01172.x10.1111/j.1524-4725.1989.tb01172.x ↗
58. 10.1097/00024720-200304000-0000110.1097/00024720-200304000-00001 ↗
59. 10.1097/00003086-199607000-0003910.1097/00003086-199607000-00039 ↗
60. 10.1097/00005131-199103000-0000110.1097/00005131-199103000-00001 ↗
61. 10.2106/00004623-199704000-0000410.2106/00004623-199704000-00004 ↗
62. 10.1016/0030-4220(89)90230-210.1016/0030-4220(89)90230-2 ↗
63. 10.1016/0278-2391(88)90046-810.1016/0278-2391(88)90046-8 ↗
64. 10.1007/BF0012030510.1007/BF00120305 ↗
65. 10.1126/science.703189910.1126/science.7031899 ↗
66. 10.1097/00000658-198110000-0000510.1097/00000658-198110000-00005 ↗
67. 10.1073/pnas.86.3.93310.1073/pnas.86.3.933 ↗
68. 10.1097/00005373-198702000-0001010.1097/00005373-198702000-00010 ↗
69. 10.1016/0305-4179(80)90038-810.1016/0305-4179(80)90038-8 ↗
70. Boyce S inventorThe regents of the University of California assignee.US5273900: Method and apparatus for preparing composite skin replacement. USA.1993.
71. 10.1016/S0149-2918(97)80043-410.1016/S0149-2918(97)80043-4 ↗
72. 10.1002/jbm.1002510.1002/jbm.10025 ↗
73. Development of antitissue factor antibodies in patients after liver surgery10.1182/blood.V82.1.96.bloodjournal82196 ↗
74. Use of absorbable collagen for hemostasis in general surgical patients
75. Use of microcrystalline collagen powder and fibrinogen tissue adhesive for hemostasis and prevention of rebleeding in patients with hepatocellular‐carcinoma associated with cirrhosis of the liver
76. Microfibrillar collagen (Avitene) as a hemostatic agent in experimental oral wounds
77. 10.1097/00006534-198402000-0005010.1097/00006534-198402000-00050 ↗
78. 10.1097/00000658-198809000-0000810.1097/00000658-198809000-00008 ↗
79. 10.1097/00004630-199001000-0000510.1097/00004630-199001000-00005 ↗
80. 10.1002/jbm.82014010810.1002/jbm.820140108 ↗
81. 10.1002/jbm.82014020310.1002/jbm.820140203 ↗
82. 10.1097/00003086-200006000-0003110.1097/00003086-200006000-00031 ↗
83. Clinical application of PGA‐tube for regeneration of intrapelvic nerves during extended surgery for intrapelvic recurrent rectal cancer
84. Clinical application of nerve conduits consisting of a polyglycolic acid (PGA)‐collagen composite tube filled with collagen sponge
85. 10.1007/978-1-4615-0717-8_8310.1007/978-1-4615-0717-8_83 ↗
86. 10.1016/S0006-8993(99)02163-010.1016/S0006-8993(99)02163-0 ↗
87. 10.1016/0142-9612(94)90094-910.1016/0142-9612(94)90094-9 ↗
88. 10.1016/0304-3940(92)90885-B10.1016/0304-3940(92)90885-B ↗
89. 10.1073/pnas.51.3.49310.1073/pnas.51.3.493 ↗
90. 10.1042/bj316000110.1042/bj3160001 ↗
91. 10.1016/S0142-9612(00)00305-710.1016/S0142-9612(00)00305-7 ↗
92. 10.1002/jbm.82023080310.1002/jbm.820230803 ↗
93. 10.1002/jbm.82029110810.1002/jbm.820291108 ↗
94. 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M ↗
95. 10.1177/03913988020250031010.1177/039139880202500310 ↗
96. 10.1016/0003-2697(90)90267-D10.1016/0003-2697(90)90267-D ↗
97. 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K ↗
98. Cross‐linkage of hydroxyapatite/collagen nano‐composite with 3 different reagents
99. 10.1016/S0142-9612(96)00106-810.1016/S0142-9612(96)00106-8 ↗
100. 10.1002/jbm.1011110.1002/jbm.10111 ↗